This is a reasonable personal preference but not a medical necessity
Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans
However, because it remains unlicensed, any supply or use outside of an approved clinical trial setting is not sanctioned by UK regulatory authorities and may be unlawful
Current treatment guidelines provide evidence-based guidance for T2D management, but they are not prescriptive and emphasize the importance of individualization of T2D management based on a patients clinical needs and preferences [2, 3]
These agents also promote 5.0% to 20% weight loss over several months and improve blood pressure and lipid profiles
The MHRA has issued repeated warnings about the dangers of purchasing injectable peptides and weight-loss compounds from unregulated online sources